Latest News

AI Eye Podcast 669: Stocks discussed: (NYSE: $AI) (NasdaqGM: $VERI)

Vancouver, Kelowna, Delta, BC – March 10, 2022 ( Newswire) (, a global investor news source covering Artificial Intelligence (AI) brings you today’s special edition of The AI Eye.

Listen to today’s podcast:

AI Eye Podcast 669: Stocks discussed: (NYSE: $AI) (NasdaqGM: $VERI)


Hear the AI Eye on Spotify

Today’s Column – The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:AI) (NasdaqGM:VERI), Inc. (NYSE:AI) has announced that the C3 AI Suite has been designated FedRAMP Ready by the U.S. Government Federal Risk and Authorization Management Program (FedRAMP). This designation renders it “easier and faster for government agencies to approve and implement the C3 AI Suite,” according to the press release. Scott Chapman, CEO of Project Hosts, a company which partners with the C3 AI Suite, said:

“As machine learning and AI drives innovation and change in the federal sector, partnerships with industry leaders like C3 AI are critical. This partnership builds upon C3 AI and Project Hosts foundations to create a FedRAMP AI solution meeting the highest security requirements required for this space.”

Veritone, Inc. (NasdaqGM:VERI) has delivered the world’s first use of multilingual synthetic voice clones for a financial results call, in having the audio script for the company’s fourth quarter and full year 2021 financial results call feature “digitally cloned voices of Chief Executive Officer Chad Steelberg, President Ryan Steelberg, Chief Financial Officer Mike Zemetra and very special guest digital twin of the legendary sports announcer Vin Scully.” Zemetra explained:

“Getting earnings data out into the market is incredibly important and often stressful as we scrutinize every detail in our script and filings. When using synthetic voice for our financial results call, my first concern was what if there are last minute changes or corrections? I discovered that Veritone Voice takes just a few minutes with updates, and it also enhances non-verbal aspects of speech such as pitch, volume, speed of delivery, rhythm and intonation – making my synthetic voice the closest version of my own voice.”

Global AI in Drug Discovery to Reach $5.55B by 2029

A report published by Research and Markets finds that the global AI in Drug Discovery market is projected to grow from $626.6 million USD in 2022 to $5.55 billion by 2029, registering a compound annual growth rate (CAGR) of 36.6 percent in the forecast period. An excerpt from the report’s description outlines some of the key applications of AI in the market:

Artificial Intelligence (AI) uses complex algorithms and machine learning to acquire significant information from huge datasets. For instance, AI uses RNA sequencing data to recognize genes whose expression correlates with a given cellular condition. It employs the most recent advancements in biology to create cutting-edge medicine discovery algorithms. The increase in computer processing power, the development of advanced algorithms, and the availability of large datasets are the main drivers that led to the developments in machine learning.

Sam Mowers,

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on visit here

About – News that Inspires Big Investing Ideas publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Stocks Podcast and the AI Eye Podcast.

The podcasts are also available on Apple Podcasts, Audible, Spotify, Tunein, Stitcher,, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire Global investors must adhere to regulations of each country. Please read privacy policy:

The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

Follow us on Twitter

Follow us on Facebook

Follow us on YouTube


800 665 0411

Buy a technology guest post on

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *